Bio-Rad Laboratories BIO
NYSE BIO
$366.15 -4.35 (-1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Bio-Rad Laboratories (BIO) Sale and Maturity of Investments (2009 - 2026)

Updated

Bio-Rad Laboratories (BIO) recorded Sale and Maturity of Investments - Total of $152.7 million in Q3 2026, down 28.8% from $214.4 million a year earlier but up 2.8% from the prior quarter.

Analysis

Bio-Rad Laboratories (BIO) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

On a TTM basis, Bio-Rad Laboratories' Sale and Maturity of Investments - Total came in at $614.4 million as of Sep 30, 2026, down 34.7% year-over-year; for FY2025, it was $855.6 million, down 34.5% from FY2024.

  • Annual Sale and Maturity of Investments - Total has a five-year compound annual growth rate of 18.4% (FY2020 to FY2025).
  • Across earlier years, Sale and Maturity of Investments - Total came in at $1.31 billion in FY2024 (+51.2%), $863.2 million in FY2023 (-19.0%), $1.07 billion in FY2022 (+39.0%) and $766.9 million in FY2021 (+108.4%).
  • Quarterly Sale and Maturity of Investments - Total has ranged from $77.88 million in Q1 2022 to $459.28 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Sale and Maturity of Investments - Total has declined for five consecutive quarters, with an average decline of 28.1% over the last eight quarters.
  • Peak year-over-year performance for Sale and Maturity of Investments - Total in the last five years was growth of 830.0% in Q4 2021, against a decline of 52.8% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $148.5 million (Q2 2026), $162.8 million (Q1 2026) and $150.4 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn -
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn -
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn -
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 2.11 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 2.21 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 89.00 Mn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 27.00 Mn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 492.50 Mn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn -
10 Bio-Rad Laboratories 9.85 Bn 3.46 Bn 328.60 Mn 152.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 152.70 Mn
Jun 30, 2026 148.50 Mn
Mar 31, 2026 162.80 Mn
Dec 31, 2025 150.40 Mn
Sep 30, 2025 214.40 Mn
Jun 30, 2025 300.10 Mn
Mar 31, 2025 190.70 Mn
Dec 31, 2024 235.30 Mn
Sep 30, 2024 407.10 Mn
Jun 30, 2024 259.30 Mn
Mar 31, 2024 403.60 Mn
Dec 31, 2023 263.32 Mn
Sep 30, 2023 230.52 Mn
Jun 30, 2023 200.52 Mn
Mar 31, 2023 168.84 Mn
Dec 31, 2022 230.63 Mn
Sep 30, 2022 368.61 Mn
Jun 30, 2022 388.88 Mn
Mar 31, 2022 77.88 Mn
Dec 31, 2021 459.28 Mn
API Access

Bio-Rad Laboratories Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=BIO&period=max&api_key=YOUR_API_KEY